Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055754) titled 'Exploration and establishment of predictive markers of intravenous glucocorticoids response in active thyroid eye disease' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tottori University Faculty of Medicine
Condition:
Condition - thyroid eye disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Establish biomarkers to predict treatment response in active thyroid eye disease requiring treatment.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Cases diagnosed as active thyroid eye disease.
Key exclusion criteria - Cases in which the physician in charge considers the patient ineligible for enrollment in the study
Target Size - 35
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2018 Year 12 Month 25 Day
Date of IRB - 2018 Year 12 Month 25 Day
Anticipated trial start date - 2018 Year 12 Month 25 Day
Last follow-up date - 2024 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063720
Disclaimer: Curated by HT Syndication.
